Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Who May Qualify: - Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data - have Glaucoma Who Should NOT Join This Trial: - Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies. - Patients with refractory CME or CME persisting 3 months or more post-operatively - Patients with incomplete IOP, medication logs or VF data within post-operative period - Prior incisional surgery or MIGS Always talk to your doctor about whether this trial is right for you.